Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complicated Intra-abdominal Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03830333
What this trial is testing

Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)

Who this might be right for
Complicated Intra-abdominal Infections
Merck Sharp & Dohme LLC 268
Large-scale testing (Phase 3)Study completedNCT02739997
What this trial is testing

Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)

Who this might be right for
Intra-abdominal InfectionComplicated Intra-abdominal Infection
Merck Sharp & Dohme LLC 100
Large-scale testing (Phase 3)Study completedNCT01069900
What this trial is testing

Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection

Who this might be right for
Intraabdominal Infections
Bayer 458
Post-approval studies (Phase 4)Study completedNCT00044928
What this trial is testing

Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection

Who this might be right for
Bacterial Infections
Wyeth is now a wholly owned subsidiary of Pfizer 262
Not applicableUnknownNCT00860587
What this trial is testing

Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections

Who this might be right for
Complicated Intra-Abdominal Infections
University Hospital, Linkoeping 200
Testing effectiveness (Phase 2)Study completedNCT06086626
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Who this might be right for
Gram-Negative Bacterial Infections
Shionogi 30
Large-scale testing (Phase 3)Study completedNCT00136201
What this trial is testing

Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections

Who this might be right for
Abdominal Abscess
Wyeth is now a wholly owned subsidiary of Pfizer 200
Testing effectiveness (Phase 2)Looking for participantsNCT06794541
What this trial is testing

Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

Who this might be right for
Complicated Intra-abdominal Infections (cIAI)
Tetraphase Pharmaceuticals, Inc 35
Testing effectiveness (Phase 2)Study completedNCT04335539
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants

Who this might be right for
Gram-negative Bacterial InfectionsBloodstream Infections (BSI)Complicated Intra-abdominal Infection (cIAI)+4 more
Shionogi 53
Large-scale testing (Phase 3)Active Not RecruitingNCT05148702
What this trial is testing

EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.

Who this might be right for
Complicated Intra-abdominal Infection
Lydia Flett 1,166
Testing effectiveness (Phase 2)Study completedNCT02475733
What this trial is testing

Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).

Who this might be right for
Complicated Intra-abdominal Infections
Pfizer 83
Large-scale testing (Phase 3)Study completedNCT03358576
What this trial is testing

Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)

Who this might be right for
Intra Abdominal Infections
Iterum Therapeutics, International Limited 674
Large-scale testing (Phase 3)Study completedNCT00210938
What this trial is testing

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

Who this might be right for
Bacterial Infections and MycosesAppendicitisCholecystitis+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 478
Post-approval studies (Phase 4)Study completedNCT00488306
What this trial is testing

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI

Who this might be right for
Abdominal Abscess
Wyeth is now a wholly owned subsidiary of Pfizer 50
Large-scale testing (Phase 3)Study completedNCT03293485
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Who this might be right for
Complicated Intra-abdominal InfectionComplicated Urinary Tract Infection
Merck Sharp & Dohme LLC 83
Not applicableLooking for participantsNCT07504510
What this trial is testing

Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease

Who this might be right for
Crohn's Disease
Sixth Affiliated Hospital, Sun Yat-sen University 300
Large-scale testing (Phase 3)Study completedNCT04927312
What this trial is testing

Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection

Who this might be right for
Complicated Intra-abdominal Infection
Pfizer 60
Post-approval studies (Phase 4)Study completedNCT00952796
What this trial is testing

A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections

Who this might be right for
Intra-abdominal Infection
Kaohsiung Medical University Chung-Ho Memorial Hospital 100
Large-scale testing (Phase 3)Study completedNCT00229060
What this trial is testing

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

Who this might be right for
Bacterial Infections and MycosesAppendicitisCholecystitis+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 483
Not applicableStudy completedNCT00683332
What this trial is testing

Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

Who this might be right for
Complicated Skin and Skin Structure InfectionsComplicated Intra-abdominal Infections
Pfizer 621
Next Page